Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d'Adda, Italy

PLoS One. 2021 Feb 24;16(2):e0246513. doi: 10.1371/journal.pone.0246513. eCollection 2021.

Abstract

Castiglione D'Adda is one of the municipalities more precociously and severely affected by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) epidemic in Lombardy. With our study we aimed to understand the diffusion of the infection by mass serological screening. We searched for SARS-CoV-2 IgGs in the entire population on a voluntary basis using lateral flow immunochromatographic tests (RICT) on capillary blood (rapid tests). We then performed chemioluminescent serological assays (CLIA) and naso-pharyngeal swabs (NPS) in a randomized representative sample and in each subject with a positive rapid test. Factors associated with RICT IgG positivity were assessed by uni- and multivariate logistic regression models. Out of the 4143 participants, 918 (22·2%) showed RICT IgG positivity. In multivariable analysis, IgG positivity increases with age, with a significant non-linear effect (p = 0·0404). We found 22 positive NPSs out of the 1330 performed. Albeit relevant, the IgG prevalence is lower than expected and suggests that a large part of the population remains susceptible to the infection. The observed differences in prevalence might reflect a different infection susceptibility by age group. A limited persistence of active infections could be found after several weeks after the epidemic peak in the area.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral / blood
  • COVID-19 / blood
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology*
  • COVID-19 / transmission*
  • COVID-19 Serological Testing / methods*
  • COVID-19 Serological Testing / statistics & numerical data
  • Cross-Sectional Studies
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin M / blood
  • Italy / epidemiology
  • Male
  • Mass Screening / methods
  • Prevalence
  • SARS-CoV-2 / genetics
  • SARS-CoV-2 / pathogenicity

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Immunoglobulin M

Grants and funding

This study was realized thanks to non-conditioning financial contributions from: CISOM (Corpo Italiano di Soccorso dell’Ordine di Malta), FC Internazionale Milano, SFD s.p.a, Emporio Armani Olimpia Milano through donations to the Dipartimento di Scienze Biomediche e Cliniche (DIBIC) of the University of Milan; from Banca Mediolanum through donation to ASST Fatebenefratelli-Sacco, Milano. Mylan Italia s.p.a. donated the rapid tests. The donations were used to cover the expenses related to personal protective equipments, materials, laboratory processing and personnel costs. None of the funding sources were involved in data collection, analysis or intepretation; trial design; patient recruitment; or any aspect pertinent to the study. Medispa s.r.l. provided support in the form of salaries for authors RR and AP; Synlab s.p.a. provided support in the form of salaries for author CO; both funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.